EUVIMED · CrossrefZeitschrift
Journal of Medicinal Chemistry
ISSN 0022-2623 · American Chemical Society (ACS)
Neueste Artikel
Lung-Tailored Pyrrolo-pyrimidine DDR Inhibitors Designed for Optimized Local Delivery
Cascade Mono- and Di-Functionalization of Anticancer Diastereomeric Benzoxazole-Ansamycins toward the Development of Highly Potent Hsp90 Inhibitors of Decreased Toxicity in Normal Cells
Alpha-Lipoic Acid Derivatives: A Multifunctional Neuroprotective Agent with Potential for Treating Ischemic Stroke
Democratizing Drug Discovery: A Scalable Open-Source Pipeline for Massive Specific Protein Target QSAR Modeling Using ChEMBL
Discovery of Orally Effective Corydamine Derivatives Targeting Glutathione Metabolism to Sensitize Hepatocellular Carcinoma to Sorafenib
Nucleic Acid Aptamers in Bacteriology: Mapping the Landscape, Exploring Bioimaging Applications, Challenges, and Future Perspectives
Development of a Potent and Isoform-Selective HDAC11 Inhibitor with Anti-Tumor Efficacy against Non-Small Cell Lung Cancer
Discovery of Potent and Non-cytotoxic HDAC3-Selective Degraders Featuring a Propyl Hydrazide Zinc-Binding Group
From Ubiquitination to Proteasome-Directed Recruiting: Emerging Mechanisms and Therapeutic Potential in Targeted Protein Degradation
Triskellines A (3,6,8-Trisubstituted [1,2,4]triazolo[4,3- b ]pyridazines) as Potent Antagonists of Human Adenosine Receptor A3
Centromere-Targeting Chimeras for Combating Cancer Drug Resistance
Discovery of Novel Quinazoline-Based KDM1A Inhibitors as Dual Inducers of Ferroptosis and Apoptosis in Esophageal Cancer
Development and Preclinical Evaluation of Six-Transmembrane Epithelial Antigen of Prostate 2 Targeted PET Probes: A Case of Drug Repurposing Based on Molecular Docking
Alkyl-Branched Acyl-Lysine Peptides as Potent Cell-Permeable Slow-Substrate Inhibitors of SIRT2
Potent and Cell Active 5-Azaindole-based Tau Tubulin Kinase Inhibitors Disrupt Ciliogenesis
Discovery of 7-Aminofuro[2,3- c ]pyridine-Based Irreversible Inhibitors of TGFβ-Activated Kinase 1 (TAK1) with In Vivo Antitumor Activity
Discovery and Optimization of Indole-Based CDK9 Inhibitors for Hepatocellular Carcinoma
Discovery of a Novel Pyrido[2,1- h ]pteridin-6-one Derivative as a Potent and Orally Bioavailable HPK1 Inhibitor
Evaluation and an Exploratory Human Study of 99mTc-Labeled PSMA-Targeting Agents with Reduced Renal Uptake via Proline Incorporation
A Modular Peptide Strategy for Targeted Lysosomal Degradation of TGF-βR1
Histone Deacetylase-Activatable BODIPY-Based G-Quadruplex Stabilizer Significantly Reducing Colon Cancer Proliferation
Design, Synthesis, and Antifibrotic Evaluation of Silicon-Incorporated Alkyl Hydrazide Analogs of Tubastatin A: HDAC3 Selective Inhibitor for Ameliorating Liver Fibrosis
Ligands Targeting α9-Containing Nicotinic Acetylcholine Receptors: Structure−Activity Relationships and Therapeutic Potential in Neuropathic Pain
Design, Synthesis, and Biological Evaluation of Novel Benzimidazole Derivatives as Dual PI3K/HDAC8 Inhibitors with Potent Anti-Cervical Cancer Activity In Vivo
Synthesis and Structure−Activity Relationship (SAR) of Hydroxypyridone-3-carboxamides against Orthopoxviruses
Discovery of Anti-apoptotic BAX Inhibitors
Synthesis, Spectroscopic, Computational, and PDT Investigations of a Series of Cationic Meso -(3-pyridyl)-indolylstyryl-BODIPYs
Discovery of Pyrazolo[1,5- a ]-1,3,5-Triazine Derivatives as Potent, Highly Selective and Orally Available Macrocyclic CDK7 Inhibitors
Chemical Determinants of Spinal Analgesia in NTS2-Selective Macrocycles
Discovery of Threonine Tyrosine Kinase (TTK) Degraders Utilizing an Electrophilic Monomethyl Fumarate Handle
Jahrgänge
2026 · 1.0792025 · 1.5672024 · 1.2862023 · 1.0292022 · 9752021 · 1.0682020 · 9732019 · 7722018 · 7972017 · 7562016 · 8372015 · 7592014 · 8362013 · 8232012 · 9252011 · 7412010 · 8182009 · 8712008 · 9252007 · 7672006 · 9222005 · 9322004 · 7812003 · 6502002 · 6662001 · 5332000 · 5761999 · 6081998 · 6341997 · 5721996 · 7371995 · 6211994 · 6121993 · 6031992 · 6851991 · 5211990 · 5331989 · 4361988 · 4141987 · 428
EUVIMED